Literature DB >> 12297129

Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells.

Cai G Huang1, Zhong L Chu, Shan J Wei, Hua Jiang, Bing H Jiao.   

Abstract

The antiplatelet effect of berberine has been demonstrated in both laboratory research and clinical trials. In the present study, we show ex vivo that berberine significantly inhibited rabbit platelet aggregation induced by adenosine diphosphate, arachidonic acid, collagen or calcium ionophore A23187. The most potent inhibition was observed in collagen-induced platelet aggregation. Using radioimmunoassay, we show in vitro that berberine significantly inhibited synthesis of thromboxane A(2) in rabbit platelets induced by adenosine diphosphate, arachidonic acid or collagen in which collagen-induced thromboxane A(2) synthesis was also most potently inhibited. In our in vivo study using radioimmunoassay, the plasma prostacyclin level was reduced by 34.6% during a 30-min period after intravenous administration of 50 mg/kg of berberine. These results suggest that berberine might inhibit arachidonic acid metabolism in rabbit platelets and endothelial cells at two or more sites: cyclooxygenase in the arachidonic acid cascade and possibly the enzyme(s) for arachidonic acid liberation from membrane phospholipid(s).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297129     DOI: 10.1016/s0049-3848(02)00133-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  13 in total

Review 1.  Advance of studies on anti-atherosclerosis mechanism of berberine.

Authors:  Min Wu; Jie Wang; Long-tao Liu
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

2.  Decrease in the production of β-amyloid by berberine inhibition of the expression of β-secretase in HEK293 cells.

Authors:  Feiqi Zhu; Fujun Wu; Ying Ma; Guangjian Liu; Zhong Li; Yong'an Sun; Zhong Pei
Journal:  BMC Neurosci       Date:  2011-12-12       Impact factor: 3.288

3.  Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease.

Authors:  Feiqi Zhu; Caiyun Qian
Journal:  BMC Neurosci       Date:  2006-12-01       Impact factor: 3.288

Review 4.  Natural Products for Antithrombosis.

Authors:  Cen Chen; Feng-Qing Yang; Qian Zhang; Feng-Qin Wang; Yuan-Jia Hu; Zhi-Ning Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

Review 5.  Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases.

Authors:  Nurul Huda Mohd Nor; Fauziah Othman; Eusni Rahayu Mohd Tohit; Sabariah Md Noor
Journal:  Thrombosis       Date:  2016-03-14

Review 6.  Study progress of berberine for treating cardiovascular disease.

Authors:  Le-Min Xia; Mei-Hong Luo
Journal:  Chronic Dis Transl Med       Date:  2016-01-12

Review 7.  Berberis vulgaris for cardiovascular disorders: a scoping literature review.

Authors:  Abdelrahman Ibrahim Abushouk; Amr Muhammad Abdo Salem; Mohamed M Abdel-Daim
Journal:  Iran J Basic Med Sci       Date:  2017-05       Impact factor: 2.699

Review 8.  Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Authors:  Xiaojun Feng; Antoni Sureda; Samineh Jafari; Zahra Memariani; Devesh Tewari; Giuseppe Annunziata; Luigi Barrea; Sherif T S Hassan; Karel Šmejkal; Milan Malaník; Alice Sychrová; Davide Barreca; Lovro Ziberna; Mohamad Fawzi Mahomoodally; Gokhan Zengin; Suowen Xu; Seyed Mohammad Nabavi; Ai-Zong Shen
Journal:  Theranostics       Date:  2019-03-16       Impact factor: 11.556

9.  Characterization of Encapsulated Berberine in Yeast Cells of Saccharomyces cerevisiae.

Authors:  Roshanak Salari; Omid Rajabi; Zahra Khashyarmanesh; Mohsen Fathi Najafi; BiBi Sedigheh Fazly Bazzaz
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Antiplatelet and Antithrombotic Activity of a Traditional Medicine, Hwangryunhaedok-Tang.

Authors:  Kyungho Kim; Hyun Ju Do; Tae Woo Oh; Kwang-Youn Kim; Tae Hoon Kim; Jin Yel Ma; Kwang-Il Park
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.